Nervgen Pharma (NGEN) Market Capitalization (2024 - 2026)

Nervgen Pharma (NGEN) has reported Market Capitalization for 3 consecutive years, with $164.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization changed N/A year-over-year to $164.1 million in Q2 2026; TTM through Jun 2026 was $164.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $446.0 million, up 190.91% from the prior year.
• Market Capitalization was $164.1 million for Q2 2026 at Nervgen Pharma, down from $300.3 million in the prior quarter.
• Over five years, Market Capitalization peaked at $446.0 million in Q4 2025 and troughed at $140.7 million in Q1 2025.
• A 3-year average of $240.9 million and a median of $164.1 million in 2026 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization jumped 190.91% in 2025 and soared 113.47% in 2026, its largest moves.
• Over 3 years, Market Capitalization stood at $153.3 million in 2024, then jumped by 190.91% to $446.0 million in 2025, then slumped by 63.21% to $164.1 million in 2026.
• The last three Market Capitalization figures came in at $164.1 million (Q2 2026), $300.3 million (Q1 2026), and $446.0 million (Q4 2025), per Business Quant data.